Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Salbutamol dose-response measured by lung function testing
NL-OMON47492Phase 4Completed
- Sponsor
- HagaZiekenhuis
- Start
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of salbutamol, sponsored by HagaZiekenhuis. Started Sep 2017; status: completed.
02
Drugs
salbutamol
Beyond the preview
Go deeper on NL-OMON47492.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON47492.